Menu
  • Join
  • Login
  • Contact
 

Library

FIP makes it a priority to publish the latest developments in pharmacy practice, pharmaceutical sciences, related global news and prominent events. Our multi-media approach to keeping members, partners and peers informed of what is and will be affecting their area of practice or science is key to keeping information flowing through the FIP network.
2019 IPJ Vol 37, No. 1 – June 2019 – Primary health care and YOU!
info
  • How mHealth applications are improving the quality of primary health care services
  • How emerging vaccine technologies are pushing disease prevention boundaries
  • Evidence supports development of a pharmacy service to screen children for hypercholesterolaemia
  • Pharmacists beating non-communicable diseases in the community
  • Interview with Sandra Carey, global president at McCann Health Global Pharmacy
  • Strengthening the role of pharmacists in primary health care in Turkey
  • How Indonesia’s pharmacists are developing their primary healthcare workforce
  • How US medical practices are integrating more pharmacists into primary healthcare teams
  • Thoughts from Fred Mayer, the USA’s “father of public health pharmacy”
  • Why we must encourage people to become active managers of their own health
  • Reports from the FIP Regional Conference for the Middle Eastern Region
2018 IPJ Vol 36, No. 2 – November 2018 – Transforming outcomes
info

Content includes:

  • Pharmacy “Amazonified”: What it could mean. 
  • FIP’s new president on modernisation. 
  • How nanotechnology breakthroughs are transforming cancer care.
  • Is antibiotic stewardship always effective?
  • Simplification: The WHO approach to eliminating hepatis C.
  • Pharmacogenetics services from community pharmacies.
  • How avatars can help improve counselling skills.
  • Conflict management: Take the offensive.
  • How to develop a strategic perspective for your faculty.
2018 IPJ Vol 36, No. 1 – June 2018 – Healthy ageing
info

Contents include: 

  • How pharmacists can improve adherence in the elderly. 
  • Tackling dementia: New drugs, new approaches, new hope. 
  • Long-term care: Optimising outcomes and being versatile. 
  • How pharmacies are helping to create age-friendly communities. 
  • Equipping health systems for 2030 and beyond. 
  • Ensuring health and happiness for Finland’s ageing
2017 IPJ Vol 35, No. 2 – November 2017 – The soul of pharmacy
info

Contents include:

  • Lebanon: Pharmacists have huge potential in the refugee crisis but must act now
  • World Congress of Pharmacy and Pharmaceutical Sciences reports
  • Neurological disease and cancer drugs are “hot” but scientists must consider market forces
  • Are you ready for Generation C?
  • Medicines shortages: What progress has been made?
  • Good enough is dead! Technology must be integrated into pharmacy education
2017 Vol 35, No. 1 – July 2017 – Future medicines for one world
info

Contents include:

  • “End-to-end thinking” is paving the way to future medicines
  • Non-profit pharma companies offering a new route to medicines
  • Interview Hiroaki Kitano: Systems biology is changing health care
  • Pharmaceutical Sciences World Congress reports
  • Developing a postgraduate course in global pharmacy
  • U-turn in Israel recognises pharmacists’ value
2016 Vol 34, No. 3 – October 2016 – Reducing the global burden of disease
info

Contents include:

  • Achieving responsible use of antimicrobial medicines
  • Rising to the challenge of reducing the global burden of disease
  • Stemming the tide of dementia in science
  • Nalfurafine: The first non-addictive opioid agonist
  • Regulatory approaches accelerate access to medicines
  • Health care education and labour markets must change
2016 Vol 34, No. 2 – July 2016 – Let’s create a better workforce
info

Contents include:

  • Interview Jim Campbell: No health without a workforce — a plan for the world
  • Continuous manufacturing: What does it mean for the pharmaceutical workforce?
  • Are pharmacists happy with their work?
  • Free movement of pharmacists in Europe: Regulation and impact
  • Brain drain/Brain gain: We need better intelligence
  • Building professional capacity in Ethiopia
2016 Vol 34, No. 1 – March 2016 – Civic Engagement
info

Contents include:

  • Leading pharmacies in complex and uncertain times 
  • Epigenetics is providing exciting targets for future medicines
  • Look beyond your immediate community: practise in low-resource and emergency settings
  • Global issues forge the path for global pharmacy citizens to follow
  • Social responsibility should be part of business as usual
  • Pharmacy and advocacy the Swiss way
2015 Vol 33, No. 3 – November 2015 – Towards better practices
info

Contents include:

  • Interview Lee Vermeulen: Inspiring developments in hospital pharmacy through international standards
  • World Congress of Pharmacy and Pharmaceutical Sciences reports
  • New omega-3-related compound kills breast cancer cells with little sign of side effects
  • Pharmacists have proved essential in the Ebola crises
  • New technologies to track compliance and administration
  • Increasing responsibilities of technicians need to be acknowledged
2015 Vol 33, No. 2 – July 2015 – Data revolution
info

Contents include:

  • Getting practical: the FIP project giving students much needed lab experience
  • Crowd power being applied to research
  • New pharmacy services and better care for patients with multiple sclerosis
  • How real-world data are improving access to medicines
  • What might be the quickest path to equip hospital pharmacists for the information age?
  • ​Big data and the pharmacist — caution advised
2015 Vol 33, No. 1 – March 2015 – Partnerships changing health
info

Contents include:

  • Interview Otmar Kloiber: Together we can prove our value better 
  • Partnerships developing treatments: tips for success
  • Developing markets where pharmacists are seen as part of the team
  • Patient partnerships giving future pharmacists better skills
  • Advanced pharmacy practice — the US landscape Healthcare for nomads and other challenges
2014 Vol 32, No. 2 – November 2014 – Making health accessible
info

Contents include:

  • Interview with Carmen Peña Professional obligation: An oath for pharmacists
  • World Congress of Pharmacy and Pharmaceutical Sciences reports
  • HIV/AIDS, tuberculosis and Fabry disease: how shortages affect patients
  • Scientists join public-private partnership to advance regulatory process
  • Pharmacy bodies could take a greater role in assuring GPP
  • Bright future for pharmacists in industry but no job entitlement
2014 Vol 33, No. 1 – June 2014 – Creating the cure
info

Contents include:

  • How virtual R&D is leading to treatments for neglected diseases
  • Getting drugs to the brain using modified nanocarriers
  • Could we be dispensing alendronate patches in future?
  • Quality by design means linking the lab to the patient early on
  • How genomics can enhance drug therapy
  • What Asia needs to do to foster pharmaceutical sciences
2013 Vol 31, No. 2 – November 2013 – Complex patients
info

Contents include:

  • Pharmacy practice in daily life Complexity everywhere?
  • World Congress of Pharmacy and Pharmaceutical Sciences reports
  • The Basel Statements: Where are we now?
  • Managing mentally ill patients: The Role of the Pharmacist
  • Better quality pharmacy education produces better pharmacists
  • Pharmaceutical sciences: Approaching the Future in Drug Delivery
2013 Vol 30, No. 1 – July 2013 – Stories from all over the world
info

Contents include:

  • How I hope to give back to the world by being a pharmacist
  • The journey thus far: pharmacy practice across continent
  • Developing medicines that are suitable for use by children
  • Providing preventative care services in a community pharmacy
  • Battling the tuberculosis pandemic in India
  • Never stop investing in yourself, never stop learning
2012 Vol 29, No. 2 – December 2012 – Centennial edition
info

Contents include:

  • Ensuring more responsible use of medicines: A report from the FIP stakeholders roundtables
  • Improving the responsible use of OTC products
  • Economics of pharmacy
  • Increased legal, social, and professional accountability
  • Traditional process vs. innovative practice
  • Past and future impact of drug development on healthcare
2012 Vol 28, No. 1 – June 2012 – The future of pharmacy
info

Contents include:

  • Global pharmacy education: Are we nearly there yet?
  • New challenges in Russia: Education responds to industry
  • Compounding in Brazil: Legal compliance for future progress
  • Change in community pharmacy policy: How are we creating it in Taiwan?
  • Team based care: Starting with the pharmacy team
  • Generating care: improving adherence through pharmacy practice
2011 Vol 27, No. 1 – June 2011 – Sustainability
info

Contents include:

  • Global reporting initiative: Reporting sustainability sector by sector
  • Decreased cost via increased access: A technology solution for sustainability
  • Rebuilding pharmaceutical systems in Afghanistan
  • Pharmaceutical systems development in sub-Saharan Africa: a call to action
  • The FIP Young Pharmacists Group supporting sustainability
  • The Amsterdam declaration: Creating a sustainable future at the FIP centennial congress
2011 Vol 27, No. 2 – October 2011 – 71 FIP world congress
info

Contents include:

  • World Congress of Pharmacy and Pharmaceutical Sciences reports
  • A reason to change Flushing our future Counterfeits
  • The magic of networking Recollections of a first timer
2011 No 27, No. 3 – December 2011 – Diseases
info

Contents include:

  • Paediatric HIV/AIDS drug formulation development: A cost reducing strategy
  • Fighting disease with attitude: Changing attitudes and behaviours about medicines in
  • Paraguay Crisis management: Legal ramifications for pharmacy practice in the face of disaster
  • A rising killer: Non-communicable diseases in development countries
  • Looking outward and forward: Fighting neglected disease with pharmaceutical sciences
  • Neglected diseases: A public health problem of low and middle-income countries only?
  • A perspective from Mexico
2010 Vol 26, No. 1 – June 2010 – Vision and innovation
info

Contents include:

  • Hands off medicines enabling good dispensing practices
  • Empowering patient minority populations self-medication management program for adult patients in custody
  • ​The value of pharmaceutical innovation global versus Indian prospective
  • Culture cross, minds meet: Uniting global scientists, highlighting pharmaceutical innovations at the
  • Pharmaceutical Sciences World Congress 2010
  • Broadening the vision: Expanding pharmacy education across borders
  • Innovation in education: Using the national science festival in
  • South Africa to raise awareness of the prevention of chronic diseases
2010 Vol 26, No. 2 – December 2010 – Journey of exploration
info

Contents include:

  • Leading FIP into the future: Dr Michel Buchmann
  • Counterfeiting high on agendas Increased responsibility: The changing role of pharmacists
  • The FIP Academic Institutional Membership: Aiming high at the inaugural deans’ forum
  • Telepharmacy: bridging the pharmacy services gap in rural and underserviced areas
  • Learning to teach: Workshop report
2009 Vol 24, No. 1 – June 2009 – Integrated science collaborative practice
info

Contents include:

  • The rise of interdisciplinary approaches: How scientists are working together for international development 
  • Collaborative care of pediatric oncology patients: Focus on the pharmacy team
  • Collaborative development of a health system-focused cardiology elective: Bringing a practice site into the classroom
  • How to get together: A collaborative help network
  • The light at the end of the tunnel? A hopeful beginning for a malaria vaccine
  • Genomics in the development of vaccines
2009 Vol 25, No. 2 – December 2009 – Patient outcomes – are you ready?
info

Contents include:

  • Making a difference: Pharmacists on the headline
  • Infectious disease: pharmacists involvement in medically-related global activities
  • Education and patient outcomes: A call for a needs-based approach
  • Continuing professional development in pharmacy practice: Is it really about learning to learn or legislating learning?
  • ​Practice, progression and regulation: Widening the discussion
2008 Vol 23, No. 2 – Great change, great responsibility
info

Content includes: 

  • Reengineering Pharmacy Practice in a Changing World
  • Cancers in Developing Countries
  • Look how far we’ve come, or have we?
  • Competence in the Global Pharmacy Workforce
  • Responsibility for Patient Outcomes: Are You Ready?
2008 Vol 22, No. 1 – The future of medicines use
info

Content includes: 

  • Industrial Manufacturing in 2020
  • Chronopharmaceutics
  • Global Conference on the Future of Hospital Pharmacy
  • Historical non-involvement and future opportunities
  • Interprofessional collaboration as a catalyst for change
2007 Vol 21, No. 2 – Evidence to reengineer pharmacy
info

Content includes: 

  • Evidence: Measurable, Tangible and Powerful
  • Stopping the Most Avoidable Risk
  • A Comprehensive Future
  • The Future of Pharmacy
  • It Will Never Happen To Me. But It Could
2007 Vol 20, No. 1 – The education issue
info

Content includes: 

FIP and WHO Establish the Pharmacy Education Taskforce
Pharmacy Education in Finland
Pharmacy Students are moving on – but how was the Journey?
23 Hard Questions for Pharmacy Educators
Dr Kamal K Midha Addresses the Pharmaceutical Sciences World Congress 2007

Webinar • 10 October 2019 - 10 October 2019

Good Storage and Distribution Practices for Pharmaceutical Products in Hospitals

More

FIP’s Hospital Pharmacy Section is organising a webinar on “Good storage and distribution practices for pharmaceutical products in hospitals”.

The correct storage and distribution and the continuous improvement of the processes involved in the supply chain from the acquisition to the administration or use of pharmaceutical products in hospitals, have a direct economic impact and improves quality assurance in patients care.

Learning objectives:

1. Understand variables that affect the stability of pharmaceutical products.

2. Understand storage and distribution processes.

3. Evaluate good storage and distribution practices that improves quality processes.

4. Highlight new technologies that benefit good practices for pharmaceutical products.

Presentation outline:

- Define variables that affect the stability of pharmaceutical products.

- Define storage and distribution processes for pharmaceutical products.

- Provide examples of good practices.

- Present new technologies that benefit good practices of storage and distribution.

Website• Contact • Add to calendar

Contact information

Address: Online
Webinar • 11 October 2019 - 11 October 2019

Good Distribution Practices: Securing the Supply Chain

More

MEPS is hosting a webinar on the topic of Good Distribution Practices which will cover all aspects of the storage/distribution chain. 

The Distribution chain has always had a great impact on the efficiency and integrity of the pharmaceutical manufacturing process, as well as safety in the ultimate use by the consumer. 

Good Distribution Practice refers to the regulatory guidelines governing the wholesale distribution of medicinal products to ensure their quality and integrity is maintained throughout the supply chain from the manufacturer to the end user. 

This webinar builds on a previous one on Good Distribution Practices. 

Learning Objectives: 

At the end of this webinar the participants will be able to: 

1. Understand the factors affecting Good Distribution Practices 


Panellist: Dr Michael Anisfield, President and Senior Consultant, Globepharm Consulting 

Chair: Mr Steve Shaddock (Vice President of MEPS) 

This webinar is open to everyone free of charge. 

Data privacy: All information requested is for use in compliance with applicable international privacy protection legislation. By completing the registration form, the participant requests that FIP uses this data to keep the participant informed of FIP activities and enhance their participation in those activities, understanding that the participant’s contact and demographic details may be made available to third parties deemed appropriate by the FIP; and, since FIP is an international organization, may be processed in any nation of the world. See the following data privacy statement: https://www.fip.org/glasgow2018/privacy-statement/ 

In a few days after the webinar, the recorded video of the webinar for individual FIP members will be available here: https://www.fip.org/webinars 

Not a member yet? Register here: http://www.fip.org/membership?page=membership_info 

We are looking forward to seeing you at the webinar. 

MEPS Team 

Website• Contact • Add to calendar

Contact information

Address: Online

A world of pharmacy data: Coming soon

This part of fip.org is still under construction. It will contain links to FIP’s online database of pharmacy-related information, organised into four categories (pharmacy and medicines regulation; pharmacy workforce and education; professional services and activities; and pharmacy remuneration models), as well as a compilation of examples of pharmacy campaigns, professional services and advocacy initiatives developed by FIP member organisations and other pharmacy-related bodies around the world.



Last update 10 May 2019

Partners

FIP works for

Our contact details Andries Bickerweg 5
2517 JP The Hague
Netherlands

+31 (0) 70 30 21 970
fip@fip.org

FIP Congresses